Vinay Prasad, a critic of the Food and Drug Administration, has been tapped as the agency’s top regulator of vaccines, gene therapies and the blood supply.

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...

The FDA plans to “rapidly make available” rare disease drugs and make use of surrogate endpoints to get promising medicines ...

The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center for Biologics Evaluation ...

Dr. Vinay Prasad, a vocal critic of the agency's moves to greenlight COVID-19 vaccine boosters. Prasad replaces Dr. Peter Marks, who served as the director of the Center for Biologics Evaluation ...

The Food and Drug Administration (FDA) has tapped Vinay Prasad ... to lead the agency’s vaccines division. Prasad replaces Peter Marks, the longtime leader of the Center for Biologics Evaluation ...

NEW ORLEANS — Last year, hundreds of people poured in to hear Peter Marks, the Food and Drug ... the gene therapy field is what stance Vinay Prasad, the fiery hematologist and frequent pharma ...

The Food and Drug Administration has named Vinay Prasad as the director of its Center for Biologics Evaluation and Research. REUTERS/Andrew Kelly/File Photo In March, Peter Marks, the FDA’s ...

The U.S. FDA has appointed Vinay Prasad to be the next director of its ... about a month after Peter Marks abruptly resigned from the position. In his resignation letter, Marks had mentioned ...